{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:34:28Z","timestamp":1784900068204,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.hrtlng.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T13:29:47Z","timestamp":1636464587000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pulmonary hypertension in adults with congenital heart disease. Clinical phenotypes and outcomes in the advanced pulmonary vasodilator era"],"prefix":"10.1016","volume":"51","author":[{"given":"Amadeo-Jos\u00e9","family":"Wals-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jose","family":"Rodriguez-Puras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Garcia-Orta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Federero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Manso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Ladr\u00f3n","family":"Abia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar Cejudo","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pastora","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2021.09.003_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2018.08.083","article-title":"Definition, clinical classification and initial diagnosis of pulmonary hypertension: updated recommendations from the cologne consensus conference 2018","volume":"272","author":"Kovacs","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.hrtlng.2021.09.003_bib0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0003","first-page":"1","article-title":"ESC scientific document group. 2020 ESC guidelines for the management of adult congenital heart disease: the task force for the management of adult congenital heart disease of the European Society of Cardiology (ESC)","volume":"00","author":"Baumgartner","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0004","first-page":"1233","article-title":"Risk factor for excess mortality in adults with congenital heart disease","volume":"38","author":"Oliver","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0006","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/eurheartj\/ehv743","article-title":"German competence network for congenital heart defects investigators. Current therapy and outcome of Eisenmenger syndrome: data of the German national register for congenital heart defects","volume":"37","author":"Diller","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0007","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2015.02.031","article-title":"Pulmonary hypertension and congenital heart disease: a insight from the REHAP national registry","volume":"184","author":"Alonso-Gonzalez","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0008","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.acvd.2017.01.006","article-title":"Outcome of adults with eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: a French multicentre study","volume":"110","author":"Hascoet","year":"2017","journal-title":"Archiv Cardiovasc Dis"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000399","article-title":"Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis","volume":"3","author":"Monfredi","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0011","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0002-9149(00)01169-3","article-title":"Mode of death in adults with congenital heart disease","volume":"86","author":"Oechslin","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0012","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/CIRCULATIONAHA.116.023033","article-title":"Predictors of death in contemporary adult patients with eisenmenger syndrome a multicenter study","volume":"135","author":"Kempny","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0013","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/eurheartj\/ehx201","article-title":"Past and current cause-specific mortality in eisenmenger s\u00edndrome","volume":"38","author":"Hjortsh\u00f8j","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0014","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.recesp.2017.11.002","article-title":"Selection of the Best of 2017 in pulmonary hypertension","volume":"71","author":"Garc\u00eda-Aranda","year":"2018","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/jcm9051456","article-title":"Pulmonary hypertension in adults with congenital heart disease: real-world data from the international COMPERA-CHD registry","volume":"9","author":"Kaemmerer","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan randomized trial of endothelin antagonist therapy-5 (BREATHE-5) investigators. Bosentan therapy in patients with eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"BREATHE-5 investigators. Long-term bosentan therapy improves functional capacity in eisenmenger syndrome: results of theBREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.118.033575","article-title":"On behalf of the MAESTRO study investigators. evaluation of macitentan in patients with eisenmenger syndrome","volume":"139","author":"Gatzoulis","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0019","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.recesp.2019.09.007","article-title":"Cardiopat\u00edas cong\u00e9nitas del adulto en Espa\u00f1a: estructura, actividad y caracter\u00edsticas cl\u00ednicas","volume":"73","author":"Oliver Ruiz","year":"2020","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/ajrccm\/145.4_Pt_1.787","article-title":"Familial pulmonary hypertension: inmunogenetics findings in four caucasian kindreds","volume":"145","author":"Morse","year":"1992","journal-title":"Am Rev Resp Dis"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0021","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0022","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijcard.2012.02.007","article-title":"Disease targeting therapies in patients with eisenmenger syndrome: response to treatment and long-term efficiency","volume":"167","author":"Diller","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0167-5273(94)90166-X","article-title":"Prognosis for patients with eisenmenger syndrome of various aetiology","volume":"45","author":"Saha","year":"1994","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0024","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9149(99)00415-4","article-title":"Determinants of survival and length of survival in adults with eisenmenger syndrome","volume":"84","author":"Cantor","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/eurheartj\/ehl116","article-title":"Presentation, survival prospects, and predictors of death in eisenmenger syndrome: a combined retrospective and case-control study","volume":"27","author":"Diller","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0026","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2008.12.087","article-title":"Heart rate variability predicts outcome in children with pulmonary arterial hypertension","volume":"142","author":"Lammers","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0027","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2017.12.010","article-title":"Pulmonary arterial hypertension-related morbidity is prognostic for mortality","volume":"71","author":"McLaughlin","year":"2018","journal-title":"JACC"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/AC.66.3.2114128","article-title":"The outcome of eisenmenger patients with trisomy 21 does not differ from patients without trisomy 21","volume":"66","author":"Troost","year":"2011","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0029","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","article-title":"Eisenmenger syndrome. Factors relating to deterioration and death","volume":"19","author":"Daliento","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/heartjnl-2011-301522","article-title":"B-type natriuretic peptide concentrations in contemporary eisenmenger syndrome patients: predictive value and response to disease targeting therapy","volume":"98","author":"Diller","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0031","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.healun.2014.08.020","article-title":"Predicting outcomes in pulmonary arterial hypertension based on the 6-min walk distance","volume":"34","author":"Farber","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0032","first-page":"840","article-title":"Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with eisenmenger syndrome","volume":"167","author":"Kempny","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0033","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ijcard.2012.12.021","article-title":"Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with eisenmenger syndrome","volume":"168","author":"Van De Bruaene","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2021.09.003_bib0034","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.112.091421","article-title":"Echocardiographic predictors of outcome in eisenmenger syndrome","volume":"126","author":"Moceri","year":"2012","journal-title":"Circulation"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956321002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956321002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:38:23Z","timestamp":1758955103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956321002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"alternative-id":["S0147956321002454"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2021.09.003","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary hypertension in adults with congenital heart disease. Clinical phenotypes and outcomes in the advanced pulmonary vasodilator era","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}